ICSI increased medical reimbursement limit from CSBF due to Covid-19

icsi

ICSI announcement says, “Considering the very grim phase the country is facing due to the phenomenal surge in Covid-19 pandemic and in order to support its stakeholders, the Company Secretaries Benevolent Fund w.e.f 1st May, 2021, has enhanced the medical reimbursement limits for those affected by Covid 19. The Members and/ or their declared dependents who have tested Covid positive from a government /ICMR authorized testing centre (only RT-PCR or Rapid Antigen Test result to be accepted) and have incurred expenses related to treatment for Covid in a hospital (private/ government/ military) or under home quarantine /isolation (on production of original bills), shall be eligible for reimbursements, with enhanced limits as under:

For Life members of CSBF : 

Limit enhanced from Rs.75,000/- (Rupees Seventy Five Thousand Only)to Rs.1,50,000/- (Rupees One Lakh Fifty Thousand Only) for self and their declared dependents.

For Life members of CSBF who have not completed 3 years of subscription (for self and their declared dependents); and for Company Secretaries who are non-members of CSBF (for self only) :

Limit enhanced from Rs.50,000/- (Rupees Fifty Thousand Only) to Rs.1,00,000/- (Rupees One Lakh Only).

As per the existing Bye Laws of the CSBF, the Annual Income criteria for deserving cases (that is Annual Income up to Rs. 7.5 Lakhs during the previous Financial Year) shall remain the same.”

Read Also: CS Exam June 2021: ICSI released the CS exams schedule

Stay safe!

Regards,
CS Nagendra D Rao
President, ICSI & Chairman-CSBF

telegram
instagram
Disclaimer:The article or blog or post (by whatever name) in this website is based on the writer’s personal views and interpretation of Act. The writer does not accept any liabilities for any loss or damage of any kind arising out of information and for any actions taken in reliance thereon. 
Also, www.babatax.com and its members do not accept any liability, obligation or responsibility for author’s article and understanding of user.

For Advertising with us-

                                                 

                                               

Tags: blog

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.
You need to agree with the terms to proceed